Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director
Quarterly results
Director departure
Asset disposition
Inv. presentation

COVETRUS, INC. (CVET) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "Third Amended and Restated Certificate of Incorporation of Covetrus, Inc",
"Second Amended and Restated Bylaws of Covetrus, Inc",
"Clayton, Dubilier & Rice and TPG Complete Acquisition of Covetrus"
10/11/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
10/03/2022 8-K Quarterly results
08/23/2022 8-K Regulation FD Disclosure  Interactive Data
08/11/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
Docs: "Covetrus Announces Financial Results for Second Quarter of 2022"
05/25/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/17/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
01/12/2022 8-K Investor presentation
Docs: "J.P. Morgan Healthcare Conference January 12, 2022 Presenters: Ben Wolin, President and CEO Matthew Foulston, EVP and CFO"
11/04/2021 8-K Quarterly results
Docs: "Covetrus Announces Financial Results for Third Quarter of 2021"
08/05/2021 8-K Quarterly results
Docs: "Covetrus Announces Financial Results for Second Quarter of 2021"
07/23/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/28/2021 8-K Quarterly results
05/18/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
04/30/2021 8-K Quarterly results
03/01/2021 8-K Quarterly results
01/13/2021 8-K Quarterly results
11/18/2020 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure  Interactive Data
11/10/2020 8-K Quarterly results
Docs: "Covetrus Announces Financial Results for Third Quarter of 2020"
09/09/2020 8-K Quarterly results
08/11/2020 8-K Quarterly results
06/25/2020 8-K Quarterly results
06/11/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Covetrus Appoints Sandi Peterson to its Board of Directors Peterson, who currently serves as an operating partner at Clayton, Dubilier & Rice, brings a wealth of global healthcare and consumer experience to the company’s board"
06/09/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/19/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "FORM 8-K",
"Certificate of Designations Classifying Series A Convertible Preferred Stock",
"Registration Rights Agreement, by and between Covetrus, Inc. and CD&R VFC Holdings, L.P"
05/14/2020 8-K Quarterly results
Docs: "Covetrus Announces Financial Results for First Quarter of 2020",
"Covetrus Announces New Members to its Senior Leadership Team Three new hires bring depth and expertise to drive the Company’s strategic plan"
05/04/2020 8-K Regulation FD Disclosure
05/01/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modifications to Rights of Secu...
Docs: "Investment Agreement, between Covetrus, Inc. and CD&R VFC Holdings, L.P",
"Covetrus Announces a $250 Million Convertible Preferred Equity Investment by Clayton, Dubilier & Rice"
04/22/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Covetrus Previews Preliminary Financial Results for the First Quarter of 2020, Provides Business and Operational Update Regarding COVID-19 Pandemic"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy